Pre-clinical study of drug combinations that reduce breast cancer burden due to aberrant mTOR and metabolism promoted by LKB1 loss

Rafaela Andrade-Vieira, Donna Goguen, Heidi A. Bentley, Chris V. Bowen, Paola A. Marignani

Résultat de recherche: Articleexamen par les pairs

22 Citations (Scopus)

Empreinte numérique

Plonger dans les sujets de recherche 'Pre-clinical study of drug combinations that reduce breast cancer burden due to aberrant mTOR and metabolism promoted by LKB1 loss'. Ensemble, ils forment une empreinte numérique unique.

Medicine & Life Sciences